3,4-Methylenedioxymethamphetamine (MDMA) Molecule

From GM-RKB
(Redirected from MDMA)
Jump to navigation Jump to search

A 3,4-Methylenedioxymethamphetamine (MDMA) Molecule is a phenethylamine.



References

2023

2016


2016

  • (2016). “F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients."
    • QUOTE: … After three doses of MDMA administered under a psychiatrist’s guidance, the patients reported a 56 percent decrease of severity of symptoms on average, one study found. By the end of the study, two-thirds no longer met the criteria for having PTSD. Follow-up examinations found that improvements lasted more than a year after therapy. …

      … “The medicine allows them to look at things from a different place and reclassify them,” said Ms. Mithoefer, a psychiatric nurse. “Honestly, we don’t have to do much. Each person has an innate ability to heal. We just create the right conditions.” …

      … The chemist Alexander Shulgin first realized the euphoria-inducing traits of MDMA in the 1970s, and introduced it to psychologists he knew. Under the nickname Adam, thousands of psychologists began to use it as an aid for therapy sessions. Some researchers at the time thought the drug could be helpful for anxiety disorders, including PTSD, but before formal clinical trails could start, Adam spread to dance clubs and college campuses under the name Ecstasy, and in 1985, the Drug Enforcement Administration made it a Schedule 1 drug, barring all legal use.

2007